Product Pipeline

SpineOvations is developing DiscSealTM to treat lower back pain caused by common disc diseases such as Degenerative Disc Disease (DDD) and Internal Disc Derangement (IDD). DiscSealTM is a proprietary formulation of biocompatible PMMA microspheres and hyaluronic acid for injection. SpineOvations is currently conducting a first-in-human a clinical study of DiscSealTM.


DiscSealTM is designed to be a minimally invasive implant to address pain and functionality targeting key unmet needs in back pain:

  • Reduction of back pain
  • Improvement in loss of motion and disability
  • Delay or potentially avoid back surgery

The DiscSealTM Value Proposition

DiscSeal’s primary intended clinical benefits are the reduction in pain and improvement in functionality for patients suffering from lower back disorders and pain related to these intervertebral disc disorders with a rapid, minimally invasive procedure.